Aripiprazole Once-monthly in Patients With Schizophrenia

Completed · Phase 3

Conditions studied: Schizophrenia

In brief

To obtain information on the safety, tolerability and effectiveness of aripiprazole once-monthly in a manner consistent with its intended use in everyday clinical practice in patients with schizophrenia who completed Study 14724A / NCT01795547.

Key facts

Study ID
NCT01959035
Run by
H. Lundbeck A/S
People needed
88
Starts
2013-10-01
Expected to finish
2015-03-01
Last updated by the study team
2017-03-17

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.